Grid Therapeutics

Developer of therapeutic antibodies

placeDurham, North Carolina, United States calendar_todayFounded 2014 groups4 employees language gridtherapeutics.com

Social engagement

Social engagement: 615 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Milestone Holdings.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon